Enum: CausalMechanismQualifierEnum
Permissible Values
| Value | Meaning | Description |
|---|---|---|
| modulation | None | A causal mechanism that effects the normal functioning of a protein in some way e.g., mixed agonist/antagonist or unclear whether action is positive or negative |
| allosteric_modulation | None | A modulation mechanism that occurs when a chemical exerts an effect on a protein targets via a different binding site than the natural ('orthosteric') ligand site. |
| mixed_allosteric_modulation | None | An allosteric modulation mechanism that occurs when a chemical may exert an activating effect or an inhibitory effect in different conditions / contexts (e.g. concentration, receptor conformational state, signaling pathway context, receptor subtype, cellular environment). |
| biphasic_allosteric_modulation | None | A mixed allosteric modulation mechanism that occurs when a chemical exerts an activating effect at lower concentrations, and an inhibitory effect at higher concentrations. |
| mixed_agonism | None | An modulation mechanism in which the effector acts as both an agonist (activating a receptor) and an antagonist (blocking a receptor) at different receptor sites. |
| positive_modulation | None | A modulation mechanism that positively effects the normal functioning of a target by increasing or enhancing its activity or abundance, or its sensitivity to other factors that do so. |
| potentiation | None | A positive modulation mechanism in which the effector binds to and enhances or intensifies the effect of some other chemical or drug on its target. |
| induction | None | A positive modulation mechanism in which the effector binds to and increases the activity/rate of an enzyme that processes drugs in the body. |
| cofactor | None | A positive modulation mechanism in which the effector (usually some non-protein chemical compound or metallic ion) is required for a target enzyme's biological/catalytic activity. |
| activation | None | A positive modulation mechanism in which the effector binds to and positively affects the normal functioning of its target. |
| positive_allosteric_modulation | None | A positive modulation mechanism in which the effector enhances the action of the endogenous ligand of a receptor by binding to a site distinct from that ligand (i.e. non-competitive inhibition) |
| agonism | None | An activation mechanism in which the effector binds and activates a receptor to mimic the effect of an endogenous ligand. |
| partial_agonism | None | An agonism mechanism in which the effector binds to and only partially activates a receptor (relative to the response to a full agonist) |
| biased_agonism | None | An agonism mechanism in which the effector binds to a receptor and activates certain signaling pathways while ignoring others, allowing it to produce a desired effect without unwanted side effects. |
| antibody_agonism | None | An agonism mechanism in which the effector is an antobody that binds and activates a receptor to mimic the effect of an endogenous ligand. |
| molecular_channel_opening | None | An activation mechanism in which the effector binds to a molecular channel and facilitates transport of ions through it. |
| stimulation | None | An activation mechanism in which the effector directly or indirectly affects its target, stimulating a physiological response. |
| guanyl_nucleotide_exchange | None | An activation mechanism in which the effector catalyzes the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) in a guanine nucleotide-binding protein (G-protein). |
| negative_modulation | None | A modulation mechanism that negatively effects the normal functioning of a target by decreasing or impeding its activity or abundance, or its sensitivity to other factors that do so. |
| negative_gene_editing_modulation | None | A negative modulation mechanism in which the effector elicits the negative modulation of its target through a gene editing activity. |
| gtpase_activation | None | An activation mechanism in which the effector accelerates the intrinsic GTPase activity of a G-protein, promoting the conversion of the active, GTP-bound form to the inactive, GDP-bound form, thereby terminating a signaling event. Note that this is a negative modulation mechanism because the target is the G-protein whose activity is attenuated through gtpase activation. |
| atpase_activation | None | An activation mechanism in which the effector accelerates the intrinsic ATPase activity of a target protein, promoting the conversion of the active, ATP-bound form to the inactive, ADP-bound form, thereby terminating a signaling event. Note that this is a negative modulation mechanism because the target is the protein whose activity is attenuated through atpase activation. |
| antisense_oligonucleotide_inhibition | None | A negative modulation mechanism in which an antisense oligonucleotide effector prevents translation of a complementary mRNA sequence through binding and targeting it for degradation. Note that while this is called "inhibition', it is not inhibition in the classic biochemical sense that requires a direct interaction between effector and target. |
| rna_interference_inhibition | None | A negative modulation mechanism in which an effector small interfering RNA (siRNA) molecule finds and destroys messenger RNA (mRNA) with a complementary sequence, preventing a specific gene from being translated into a protein. Note that while this is called "inhibition', it is not inhibition in the classic biochemical sense that requires a direct interaction between effector and target. |
| suppression | None | A negative modulation mechanism in which the effector directly or indirectly affects its target, suppressing a physiological process. |
| feedback_inhibition | None | An negative modulation mechanism in which the end product of a metabolic pathway inhibits an enzyme early in that same pathway, which stops the production of the final product when it's no longer needed. |
| inhibition | None | A negative modulation mechanism in which the effector binds to the target and negatively effects its normal function, e.g. prevention of enzymatic reaction or activation of downstream pathway. |
| antibody_inhibition | None | An inhibition mechanism in which an antibody effector specifically binds to and interferes with the target. |
| antagonism | None | An inhibition mechanism in which the effector binds to a receptor and prevents activation by an agonist through competing for the binding site. |
| allosteric_antagonism | None | An inhibition mechanism in which the effector binds to a receptor at an allosteric site and prevents activation by a positive allosteric modulator at that site. |
| non_competitive_antagonism | None | An inhibition mechanism in which the effector binds a site distinct from the agonist's binding site (non-orthosteric), or irreversibly/insurmountably inactivates the receptor - reduces the receptor’s maximal response (Emax) in a way that cannot be overcome by adding more agonist. |
| competitive_inhibition | None | An inhibition mechanism in which the effector binds to a target molecule (such as an enzyme) and prevents the binding of a substrate (or another binding partner) and vice versa. |
| noncompetitive_inhibition | None | An inhibition mechanism in which the effector binds to a target molecule (such as an enzyme) at a site other than the active site, in a way that reduces the activity of the target. |
| negative_allosteric_modulation | None | A noncompetitive inhibition mechanism in which the effector reduces or prevents the action of the endogenous ligand of a receptor by binding to a site distinct from that ligand, and causing a conformational change that affects ligand binding. |
| gating_inhibition | None | An inhibition mechanism mediated by the transition of ion channels between their open (conducting) and closed (non-conducting) conformational states. |
| irreversible_inhibition | None | An inhibition mechanism in which an effector permanently binds to a target, permanently disrupting its activity. |
| molecular_channel_blockage | None | An inhibition mechanism in which the effector binds to a molecular channel and prevents or reduces transport of ions through it. |
| inverse_agonism | None | An inhibition mechanism in which the effector binds to the same receptor-binding site as an agonist and antagonizes its effects, often exerting the opposite effect of the agonist by suppressing spontaneous receptor signaling. |
| binding | None | A modulation mechanism mediated by the direct contact between effector and target chemical or biomolecular entity, which form a stable physical interaction (typically non-covalent). |
| covalent_binding | None | A modulation mechanism mediated by a direct covalent binding interaction between effector and target chemical or biomolecular entity. |
| adduction | None | A covalent binding mechanism in which a drug-protein adduct forms by the covalent binding of electrophilic drugs or their reactive metabolite(s) to a target protein. |
| crosslinking | None | A covalent binding mechanism in which an effector induces cross-linking of target proteins or nucleic acids - covalently joining them into a rigid structure. |
| transglutamination | None | A covalent binding mechanism involving formation of a covalent bond between a glutamine residue and an amine as catalyzed by a transglutaminase. |
| disuphide_binding | None | A covalent binding mechanism involving a covalent bond formed between two cysteine residues in or between proteins. |
| stabilization | None | A modulation mechanism in which the effector increases the conformational stability of a protein or complex. |
| chaperone_mediated_stabilization | None | |
| destabilization | None | A modulation mechanism in which a chaperone molecule directly binds to a partially folded biosynthetic intermediate to stabilize the protein and allow it to complete the folding process to yield a functional protein. |
| degradation | None | A modulation mechanism that controls protein and cellular component levels through the regulated breakdown and recycling of molecules. |
| cleavage | None | A modulation mechanism in which an effector promotes degeneration of the target protein through cleaving of the peptide bonds. |
| hydrolysis | None | A modulation mechanism in which an effector cleaves its target through a chemical reaction where a molecule of water is used to break a bond. |
| disruption | None | A modulation mechanism in which an effector destabilizes or disrupts a protein complex, macromolecular assembly, cell membrane etc. |
| opening | None | A modulation mechanism in which an effector positively effects the normal functioning of an ion channel e.g., facilitates transport of ions through the channel. |
| multitarget_modulation | None | A modulation mechanism in which an effector achieves a physiological effect through simultaneous interaction with multiple gene targets. |
| chelation | None | A modulation mechanism in which an effector binds to a metal ion target, reducing its availability/reactivity for further interactions. |
| release | None | A modulation mechanism in which an effector reverses the normal functioning of a transporter, causing release of the substrate, rather than uptake |
| sequestration | None | A modulation mechanism in which an effector binds to a substance such as a drug, toxin or metabolite and reduces its availability for further interactions. |
| oxidoreduction | None | A modulation mechanism in which in which electrons are transferred between molecules catalyzed by an oxidoreductase enzyme. |
| exogenous_protein | None | A modulation mechanism in which a protein from an exogenous source acts as a substitute or supplement for a specific protein which is absent or has reduced function in an affected target/subject. |
| exogenous_gene | None | A modulation mechanism in which a nucleic acid from an exogenous source acts as a substitute or supplement for a specific gene which is absent or has reduced function in an affected target/subject. |
| transcriptional_regulation | None | A modulation mechanism mediated by through the control of target gene transcription. |
| translational_regulation | None | A modulation mechanism mediated by through the control of target gene translation. |
| catalytic_activity | None | A modulation mechanism mediated by through the catalytic activity of the effector on the target. |
| chemical_modification | None | A modulation mechanism mediated by a protein/complex effector altering a small molecule by modifying it or converting it to something else. |
| relocalization | None | A modulation mechanism mediated by an effector that alters the localization of a target in the cell or body. |
| isomerization | None | A modulation mechanism mediated by an effector that alters the isomeric conformation of a target. |
| signaling_mediated_control | None | A modulation mechanism mediated by the activation or control of signaling events that influence the some aspect of the target entity (e.g. its activity, processing, transport, etc.). |
| immune_system_modulation | None | A modulation mechanism in which the actions of the effector on the immune system ultimately mediate the affects a target. |
| vaccine_antigen | None | An immune system modulation mechanism in which a vaccine mediates its effect through the activation of the immune system against the target. |
| post_transcriptional_regulation | None | A modulation mechanism which controls expression of a target gene at the RNA level after a gene has been transcribed into messenger RNA (mRNA). |
| molecular_modification | None | A modulation mechanism through which an effect is mediated by the modification of a target, through addition of chemical moieties such phosphate groups, ubiquitin, lipids, etc., which alter its activity or cellular behavior. |
| phosphorylation | None | None |
| dephosphorylation | None | None |
| neddylation | None | None |
| deneddylation | None | None |
| lipidation | None | None |
| palmitoylation | None | None |
| myristoylation | None | None |
| tyrosination | None | None |
| carboxylation | None | None |
| ubiquitination | None | None |
| monoubiquitination | None | None |
| polyubiquitination | None | None |
| deubiquitination | None | None |
| sulfation | None | None |
| reduction | None | A molecular modification mechanism in which an effector modifies a target substrate via a reduction reaction. |
| oxidation | None | A molecular modification mechanism in which an effector modifies a target substrate via an oxidation reaction. |
| acetylation | None | None |
| deacetylation | None | None |
| glycosylation | None | None |
| deglycosylation | None | None |
| methylation | None | None |
| trimethylation | None | None |
| demethylation | None | None |
| sumoylation | None | None |
| desumoylation | None | None |
| ADP-ribosylation | None | None |
| de-ADP-ribosylation | None | None |
| ampylation | None | A molecular modification involving the addition of an adenylyl (AMP) moiety to a substrate protein residue. |
| hydroxylation | None | None |
| s_nitrosylation | None | None |
Slots constrained by this enum
| Name |
|---|
| causal_mechanism_qualifier |
| causal_mechanism_qualifier |
LinkML Source
name: CausalMechanismQualifierEnum
from_schema: https://w3id.org/biolink/vocab/
permissible_values:
modulation:
text: modulation
description: A causal mechanism that effects the normal functioning of a protein
in some way e.g., mixed agonist/antagonist or unclear whether action is positive
or negative
allosteric_modulation:
text: allosteric_modulation
description: A modulation mechanism that occurs when a chemical exerts an effect
on a protein targets via a different binding site than the natural ('orthosteric')
ligand site.
is_a: modulation
mixed_allosteric_modulation:
text: mixed_allosteric_modulation
description: An allosteric modulation mechanism that occurs when a chemical may
exert an activating effect or an inhibitory effect in different conditions /
contexts (e.g. concentration, receptor conformational state, signaling pathway
context, receptor subtype, cellular environment).
is_a: allosteric_modulation
biphasic_allosteric_modulation:
text: biphasic_allosteric_modulation
description: A mixed allosteric modulation mechanism that occurs when a chemical
exerts an activating effect at lower concentrations, and an inhibitory effect
at higher concentrations.
is_a: mixed_allosteric_modulation
mixed_agonism:
text: mixed_agonism
description: An modulation mechanism in which the effector acts as both an agonist
(activating a receptor) and an antagonist (blocking a receptor) at different
receptor sites.
is_a: modulation
positive_modulation:
text: positive_modulation
description: A modulation mechanism that positively effects the normal functioning
of a target by increasing or enhancing its activity or abundance, or its sensitivity
to other factors that do so.
is_a: modulation
potentiation:
text: potentiation
description: A positive modulation mechanism in which the effector binds to and
enhances or intensifies the effect of some other chemical or drug on its target.
is_a: positive_modulation
induction:
text: induction
description: A positive modulation mechanism in which the effector binds to and
increases the activity/rate of an enzyme that processes drugs in the body.
is_a: positive_modulation
close_mappings:
- DGIdb:inducer
cofactor:
text: cofactor
description: A positive modulation mechanism in which the effector (usually some
non-protein chemical compound or metallic ion) is required for a target enzyme's
biological/catalytic activity.
is_a: positive_modulation
activation:
text: activation
description: A positive modulation mechanism in which the effector binds to and
positively affects the normal functioning of its target.
is_a: positive_modulation
close_mappings:
- CHEMBL.MECHANISM:activator
- DGIdb:activator
positive_allosteric_modulation:
text: positive_allosteric_modulation
description: A positive modulation mechanism in which the effector enhances the
action of the endogenous ligand of a receptor by binding to a site distinct
from that ligand (i.e. non-competitive inhibition)
is_a: activation
close_mappings:
- CHEMBL.MECHANISM:positive_allosteric_modulator
- CHEMBL.MECHANISM:positive_modulator
- DGIdb:positive_allosteric_modulator
broad_mappings:
- DGIdb:modulator
- DGIdb:allosteric_modulator
agonism:
text: agonism
description: An activation mechanism in which the effector binds and activates
a receptor to mimic the effect of an endogenous ligand.
is_a: activation
close_mappings:
- CHEMBL.MECHANISM:agonist
- DGIdb:agonist
narrow_mappings:
- CHEMBL.MECHANISM:partial_agonist
- DGIdb:partial_agonist
partial_agonism:
text: partial_agonism
description: An agonism mechanism in which the effector binds to and only partially
activates a receptor (relative to the response to a full agonist)
is_a: agonism
biased_agonism:
text: biased_agonism
description: An agonism mechanism in which the effector binds to a receptor and
activates certain signaling pathways while ignoring others, allowing it to produce
a desired effect without unwanted side effects.
is_a: agonism
antibody_agonism:
text: antibody_agonism
description: An agonism mechanism in which the effector is an antobody that binds
and activates a receptor to mimic the effect of an endogenous ligand.
is_a: agonism
molecular_channel_opening:
text: molecular_channel_opening
description: An activation mechanism in which the effector binds to a molecular
channel and facilitates transport of ions through it.
is_a: activation
close_mappings:
- CHEMBL.MECHANISM:opener
stimulation:
text: stimulation
description: An activation mechanism in which the effector directly or indirectly
affects its target, stimulating a physiological response.
is_a: activation
close_mappings:
- DGIdb:stimulator
- SEMMEDDB:STIMULATES
- DGIdb:stimulator
guanyl_nucleotide_exchange:
text: guanyl_nucleotide_exchange
description: An activation mechanism in which the effector catalyzes the exchange
of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) in a guanine
nucleotide-binding protein (G-protein).
is_a: activation
negative_modulation:
text: negative_modulation
description: A modulation mechanism that negatively effects the normal functioning
of a target by decreasing or impeding its activity or abundance, or its sensitivity
to other factors that do so.
is_a: modulation
narrow_mappings:
- DGIdb:negative_modulator
negative_gene_editing_modulation:
text: negative_gene_editing_modulation
description: A negative modulation mechanism in which the effector elicits the
negative modulation of its target through a gene editing activity.
is_a: negative_modulation
gtpase_activation:
text: gtpase_activation
description: An activation mechanism in which the effector accelerates the intrinsic
GTPase activity of a G-protein, promoting the conversion of the active, GTP-bound
form to the inactive, GDP-bound form, thereby terminating a signaling event.
Note that this is a negative modulation mechanism because the target is the
G-protein whose activity is attenuated through gtpase activation.
is_a: negative_modulation
atpase_activation:
text: atpase_activation
description: An activation mechanism in which the effector accelerates the intrinsic
ATPase activity of a target protein, promoting the conversion of the active,
ATP-bound form to the inactive, ADP-bound form, thereby terminating a signaling
event. Note that this is a negative modulation mechanism because the target
is the protein whose activity is attenuated through atpase activation.
is_a: negative_modulation
antisense_oligonucleotide_inhibition:
text: antisense_oligonucleotide_inhibition
description: A negative modulation mechanism in which an antisense oligonucleotide
effector prevents translation of a complementary mRNA sequence through binding
and targeting it for degradation. Note that while this is called "inhibition',
it is not inhibition in the classic biochemical sense that requires a direct
interaction between effector and target.
is_a: negative_modulation
rna_interference_inhibition:
text: rna_interference_inhibition
description: A negative modulation mechanism in which an effector small interfering
RNA (siRNA) molecule finds and destroys messenger RNA (mRNA) with a complementary
sequence, preventing a specific gene from being translated into a protein. Note
that while this is called "inhibition', it is not inhibition in the classic
biochemical sense that requires a direct interaction between effector and target.
is_a: negative_modulation
suppression:
text: suppression
description: A negative modulation mechanism in which the effector directly or
indirectly affects its target, suppressing a physiological process.
is_a: negative_modulation
feedback_inhibition:
text: feedback_inhibition
description: An negative modulation mechanism in which the end product of a metabolic
pathway inhibits an enzyme early in that same pathway, which stops the production
of the final product when it's no longer needed.
is_a: negative_modulation
inhibition:
text: inhibition
description: A negative modulation mechanism in which the effector binds to the
target and negatively effects its normal function, e.g. prevention of enzymatic
reaction or activation of downstream pathway.
is_a: negative_modulation
close_mappings:
- DGIdb:inhibitor
- SEMMEDDB:INHIBITS
narrow_mappings:
- DGIdb:blocker
- DGIdb:channel_blocker
- DGIdb:gating_inhibitor
- CHEMBL.MECHANISM:antisense_inhibitor
- CHEMBL.MECHANISM:blocker
- CHEMBL.MECHANISM:inhibitor
- CHEMBL.MECHANISM:negative_allosteric_modulator
- CHEMBL.MECHANISM:negative_modulator
- DGIdb:negative_modulator
antibody_inhibition:
text: antibody_inhibition
description: An inhibition mechanism in which an antibody effector specifically
binds to and interferes with the target.
is_a: inhibition
antagonism:
text: antagonism
description: An inhibition mechanism in which the effector binds to a receptor
and prevents activation by an agonist through competing for the binding site.
is_a: inhibition
close_mappings:
- DGIdb:antagonist
- CHEMBL.MECHANISM:antagonist
narrow_mappings:
- CHEMBL.MECHANISM:allosteric_antagonist
allosteric_antagonism:
text: allosteric_antagonism
description: An inhibition mechanism in which the effector binds to a receptor
at an allosteric site and prevents activation by a positive allosteric modulator
at that site.
is_a: antagonism
non_competitive_antagonism:
text: non_competitive_antagonism
description: An inhibition mechanism in which the effector binds a site distinct
from the agonist's binding site (non-orthosteric), or irreversibly/insurmountably
inactivates the receptor - reduces the receptor’s maximal response (Emax) in
a way that cannot be overcome by adding more agonist.
is_a: antagonism
competitive_inhibition:
text: competitive_inhibition
description: An inhibition mechanism in which the effector binds to a target molecule
(such as an enzyme) and prevents the binding of a substrate (or another binding
partner) and vice versa.
is_a: inhibition
noncompetitive_inhibition:
text: noncompetitive_inhibition
description: An inhibition mechanism in which the effector binds to a target molecule
(such as an enzyme) at a site other than the active site, in a way that reduces
the activity of the target.
is_a: inhibition
negative_allosteric_modulation:
text: negative_allosteric_modulation
description: A noncompetitive inhibition mechanism in which the effector reduces
or prevents the action of the endogenous ligand of a receptor by binding to
a site distinct from that ligand, and causing a conformational change that affects
ligand binding.
is_a: noncompetitive_inhibition
close_mappings:
- CHEMBL.MECHANISM:negative_allosteric_modulator
- DGIdb:inhibitory_allosteric_modulator
gating_inhibition:
text: gating_inhibition
description: An inhibition mechanism mediated by the transition of ion channels
between their open (conducting) and closed (non-conducting) conformational states.
is_a: inhibition
irreversible_inhibition:
text: irreversible_inhibition
description: An inhibition mechanism in which an effector permanently binds to
a target, permanently disrupting its activity.
is_a: inhibition
molecular_channel_blockage:
text: molecular_channel_blockage
description: An inhibition mechanism in which the effector binds to a molecular
channel and prevents or reduces transport of ions through it.
is_a: inhibition
inverse_agonism:
text: inverse_agonism
description: An inhibition mechanism in which the effector binds to the same receptor-binding
site as an agonist and antagonizes its effects, often exerting the opposite
effect of the agonist by suppressing spontaneous receptor signaling.
is_a: inhibition
close_mappings:
- CHEMBL.MECHANISM:inverse_agonist
- DGIdb:inverse_agonist
binding:
text: binding
description: A modulation mechanism mediated by the direct contact between effector
and target chemical or biomolecular entity, which form a stable physical interaction
(typically non-covalent).
is_a: modulation
covalent_binding:
text: covalent_binding
description: A modulation mechanism mediated by a direct covalent binding interaction
between effector and target chemical or biomolecular entity.
is_a: modulation
adduction:
text: adduction
description: A covalent binding mechanism in which a drug-protein adduct forms
by the covalent binding of electrophilic drugs or their reactive metabolite(s)
to a target protein.
is_a: covalent_binding
crosslinking:
text: crosslinking
description: A covalent binding mechanism in which an effector induces cross-linking
of target proteins or nucleic acids - covalently joining them into a rigid structure.
is_a: covalent_binding
transglutamination:
text: transglutamination
description: A covalent binding mechanism involving formation of a covalent bond
between a glutamine residue and an amine as catalyzed by a transglutaminase.
is_a: covalent_binding
disuphide_binding:
text: disuphide_binding
description: A covalent binding mechanism involving a covalent bond formed between
two cysteine residues in or between proteins.
is_a: covalent_binding
stabilization:
text: stabilization
description: A modulation mechanism in which the effector increases the conformational
stability of a protein or complex.
is_a: modulation
close_mappings:
- CHEMBL.MECHANISM:stabiliser
chaperone_mediated_stabilization:
text: chaperone_mediated_stabilization
description: ''
is_a: stabilization
destabilization:
text: destabilization
description: A modulation mechanism in which a chaperone molecule directly binds
to a partially folded biosynthetic intermediate to stabilize the protein and
allow it to complete the folding process to yield a functional protein.
is_a: modulation
degradation:
text: degradation
description: A modulation mechanism that controls protein and cellular component
levels through the regulated breakdown and recycling of molecules.
is_a: modulation
cleavage:
text: cleavage
description: A modulation mechanism in which an effector promotes degeneration
of the target protein through cleaving of the peptide bonds.
is_a: modulation
hydrolysis:
text: hydrolysis
description: A modulation mechanism in which an effector cleaves its target through
a chemical reaction where a molecule of water is used to break a bond.
is_a: modulation
disruption:
text: disruption
description: A modulation mechanism in which an effector destabilizes or disrupts
a protein complex, macromolecular assembly, cell membrane etc.
is_a: modulation
opening:
text: opening
description: A modulation mechanism in which an effector positively effects the
normal functioning of an ion channel e.g., facilitates transport of ions through
the channel.
is_a: modulation
multitarget_modulation:
text: multitarget_modulation
description: A modulation mechanism in which an effector achieves a physiological
effect through simultaneous interaction with multiple gene targets.
is_a: modulation
chelation:
text: chelation
description: A modulation mechanism in which an effector binds to a metal ion
target, reducing its availability/reactivity for further interactions.
is_a: modulation
release:
text: release
description: A modulation mechanism in which an effector reverses the normal functioning
of a transporter, causing release of the substrate, rather than uptake
is_a: modulation
close_mappings:
- CHEMBL:MECHANISM:releasing_agent
sequestration:
text: sequestration
description: A modulation mechanism in which an effector binds to a substance
such as a drug, toxin or metabolite and reduces its availability for further
interactions.
is_a: modulation
oxidoreduction:
text: oxidoreduction
description: A modulation mechanism in which in which electrons are transferred
between molecules catalyzed by an oxidoreductase enzyme.
is_a: modulation
exogenous_protein:
text: exogenous_protein
description: A modulation mechanism in which a protein from an exogenous source
acts as a substitute or supplement for a specific protein which is absent or
has reduced function in an affected target/subject.
is_a: modulation
exogenous_gene:
text: exogenous_gene
description: A modulation mechanism in which a nucleic acid from an exogenous
source acts as a substitute or supplement for a specific gene which is absent
or has reduced function in an affected target/subject.
is_a: modulation
transcriptional_regulation:
text: transcriptional_regulation
description: A modulation mechanism mediated by through the control of target
gene transcription.
is_a: modulation
translational_regulation:
text: translational_regulation
description: A modulation mechanism mediated by through the control of target
gene translation.
is_a: modulation
catalytic_activity:
text: catalytic_activity
description: A modulation mechanism mediated by through the catalytic activity
of the effector on the target.
is_a: modulation
chemical_modification:
text: chemical_modification
description: A modulation mechanism mediated by a protein/complex effector altering
a small molecule by modifying it or converting it to something else.
is_a: modulation
relocalization:
text: relocalization
description: A modulation mechanism mediated by an effector that alters the localization
of a target in the cell or body.
is_a: modulation
isomerization:
text: isomerization
description: A modulation mechanism mediated by an effector that alters the isomeric
conformation of a target.
is_a: modulation
signaling_mediated_control:
text: signaling_mediated_control
description: A modulation mechanism mediated by the activation or control of signaling
events that influence the some aspect of the target entity (e.g. its activity,
processing, transport, etc.).
is_a: modulation
immune_system_modulation:
text: immune_system_modulation
description: A modulation mechanism in which the actions of the effector on the
immune system ultimately mediate the affects a target.
is_a: modulation
vaccine_antigen:
text: vaccine_antigen
description: An immune system modulation mechanism in which a vaccine mediates
its effect through the activation of the immune system against the target.
is_a: immune_system_modulation
post_transcriptional_regulation:
text: post_transcriptional_regulation
description: A modulation mechanism which controls expression of a target gene
at the RNA level after a gene has been transcribed into messenger RNA (mRNA).
is_a: modulation
molecular_modification:
text: molecular_modification
description: A modulation mechanism through which an effect is mediated by the
modification of a target, through addition of chemical moieties such phosphate
groups, ubiquitin, lipids, etc., which alter its activity or cellular behavior.
is_a: modulation
phosphorylation:
text: phosphorylation
is_a: molecular_modification
dephosphorylation:
text: dephosphorylation
is_a: molecular_modification
neddylation:
text: neddylation
is_a: molecular_modification
deneddylation:
text: deneddylation
is_a: molecular_modification
lipidation:
text: lipidation
is_a: molecular_modification
palmitoylation:
text: palmitoylation
is_a: lipidation
myristoylation:
text: myristoylation
is_a: lipidation
tyrosination:
text: tyrosination
is_a: molecular_modification
carboxylation:
text: carboxylation
is_a: molecular_modification
ubiquitination:
text: ubiquitination
is_a: molecular_modification
monoubiquitination:
text: monoubiquitination
is_a: ubiquitination
polyubiquitination:
text: polyubiquitination
is_a: ubiquitination
deubiquitination:
text: deubiquitination
is_a: molecular_modification
sulfation:
text: sulfation
is_a: molecular_modification
reduction:
text: reduction
description: A molecular modification mechanism in which an effector modifies
a target substrate via a reduction reaction.
is_a: molecular_modification
oxidation:
text: oxidation
description: A molecular modification mechanism in which an effector modifies
a target substrate via an oxidation reaction.
is_a: molecular_modification
acetylation:
text: acetylation
is_a: molecular_modification
deacetylation:
text: deacetylation
is_a: molecular_modification
glycosylation:
text: glycosylation
is_a: molecular_modification
deglycosylation:
text: deglycosylation
is_a: molecular_modification
methylation:
text: methylation
is_a: molecular_modification
trimethylation:
text: trimethylation
is_a: methylation
demethylation:
text: demethylation
is_a: molecular_modification
sumoylation:
text: sumoylation
is_a: molecular_modification
desumoylation:
text: desumoylation
is_a: molecular_modification
ADP-ribosylation:
text: ADP-ribosylation
is_a: molecular_modification
de-ADP-ribosylation:
text: de-ADP-ribosylation
is_a: molecular_modification
ampylation:
text: ampylation
description: A molecular modification involving the addition of an adenylyl (AMP)
moiety to a substrate protein residue.
is_a: molecular_modification
hydroxylation:
text: hydroxylation
is_a: molecular_modification
s_nitrosylation:
text: s_nitrosylation
is_a: molecular_modification